Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co.

Sanyou signs two commercial-use licenses for Horizon’s gene-edited CHO-K1 GS knockout cell line, for use in biotherapeutic pipeline development and contract research services